High prevalence of fatigue in contemporary patients with multiple sclerosis

por Broch, Line, Simonsen, Cecilia Smith, Flemmen, Heidi Øyen, Berg-Hansen, Pål, Skardhamar, Åshild, Ormstad, Heidi, Celius, Elisabeth Gulowsen
Publicado 2021

Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population

por Simonsen, Cecilia Smith, Flemmen, Heidi Øyen, Broch, Line, Brekke, Kamilla, Brunborg, Cathrine, Berg-Hansen, Pål, Celius, Elisabeth Gulowsen
Publicado 2022

The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression

por Simonsen, Cecilia Smith, Flemmen, Heidi Øyen, Broch, Line, Brunborg, Cathrine, Berg-Hansen, Pål, Moen, Stine Marit, Celius, Elisabeth Gulowsen
Publicado 2020

Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry

por Simonsen, Cecilia Smith, Flemmen, Heidi Øyen, Broch, Line, Brunborg, Cathrine, Berg-Hansen, Pål, Moen, Stine Marit, Celius, Elisabeth Gulowsen
Publicado 2021